Dimensional Fund Advisors LP Arcus Biosciences, Inc. Transaction History

Dimensional Fund Advisors LP

$418 Billion
Q2 2025

A detailed history of Dimensional Fund Advisors LP transactions in Arcus Biosciences, Inc. stock. As of the latest transaction made, Dimensional Fund Advisors LP holds 1,659,879 shares of RCUS stock, worth $19.1 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

1,659,879

Previous 1,722,083 3.61%

Holding current value

$19.1 Million

Previous $13.5 Million 0.05%

% of portfolio

0.0%

Previous 0.0%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 12, 2025	SELL	$6.87 - $10.03 $427,341 - $623,906	-62,204 Reduced 3.61%	1,659,879 $13.5 Million
Q1 2025 May 13, 2025	BUY	$7.85 - $15.24 $155,280 - $301,462	19,781 Added 1.16%	1,722,083 $13.5 Million
Q4 2024 Feb 13, 2025	BUY	$14.28 - $18.44 $2.55 Million - $3.29 Million	178,351 Added 11.7%	1,702,302 $25.3 Million
Q3 2024 Nov 07, 2024	BUY	$13.69 - $18.01 $606,795 - $798,275	44,324 Added 3.0%	1,523,951 $23.3 Million
Q2 2024 Aug 09, 2024	SELL	$14.59 - $18.48 $2.07 Million - $2.62 Million	-141,782 Reduced 8.74%	1,479,627 $22.5 Million
Q1 2024 May 10, 2024	BUY	$14.83 - $20.18 $397,444 - $540,824	26,800 Added 1.68%	1,621,409 $30.6 Million
Q4 2023 Feb 07, 2024	BUY	$13.43 - $19.63 $2.12 Million - $3.1 Million	158,094 Added 11.01%	1,594,609 $30.5 Million
Q3 2023 Nov 09, 2023	BUY	$17.62 - $23.54 $5.23 Million - $6.99 Million	297,035 Added 26.07%	1,436,515 $25.8 Million
Q2 2023 Aug 09, 2023	SELL	$16.97 - $22.03 $2.84 Million - $3.69 Million	-167,597 Reduced 12.82%	1,139,480 $23.1 Million
Q1 2023 May 12, 2023	BUY	$15.96 - $23.15 $4.99 Million - $7.24 Million	312,887 Added 31.47%	1,307,077 $23.8 Million
Q4 2022 Feb 09, 2023	BUY	$19.7 - $35.71 $6.19 Million - $11.2 Million	314,096 Added 46.18%	994,190 $20.6 Million
Q3 2022 Nov 10, 2022	BUY	$23.23 - $30.07 $8.35 Million - $10.8 Million	359,339 Added 112.03%	680,094 $17.8 Million
Q2 2022 Aug 12, 2022	SELL	$17.23 - $37.73 $2.02 Million - $4.42 Million	-117,214 Reduced 26.76%	320,755 $8.13 Million
Q1 2022 May 13, 2022	BUY	$28.92 - $41.83 $5.51 Million - $7.97 Million	190,527 Added 77.0%	437,969 $13.8 Million
Q4 2021 Feb 09, 2022	BUY	$31.38 - $48.47 $6.54 Million - $10.1 Million	208,543 Added 536.11%	247,442 $10 Million
Q3 2021 Nov 12, 2021	BUY	$26.93 - $37.68 $110,386 - $154,450	4,099 Added 11.78%	38,899 $1.36 Million
Q2 2021 Aug 12, 2021	BUY	$22.75 - $35.77 $791,700 - $1.24 Million	34,800 New	34,800 $956,000
Q1 2021 May 14, 2021	SELL	$26.16 - $41.39 $5.2 Million - $8.23 Million	-198,754 Closed	0 $0
Q4 2020 Feb 25, 2021	BUY	$17.0 - $32.36 $3.38 Million - $6.43 Million	198,754 New	198,754 $5.16 Million

Others Institutions Holding RCUS

# of Institutions

208

Shares Held

67M

Call Options Held

3.18M

Put Options Held

167K

View Full List

About Arcus Biosciences, Inc.

Ticker RCUS
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 72,160,000
Market Cap $831M
Description
Arcus Biosciences, Inc., a clinical-stage biopharmaceutical company, develops and commercializes cancer therapies in the United States. Its product pipeline includes, Etrumadenant, a dual A2a/A2b adenosine receptor antagonist, which is in a Phase 1b/2 clinical trial; and Zimberelimab, an anti-PD-1 antibody that is in Phase 1b clinical trial for ...

More about RCUS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Dimensional Fund Advisors LP, based on Form 13F filings with the SEC.

News

Stay updated on Dimensional Fund Advisors LP with notifications on news.

Account

Dimensional Fund Advisors LP Arcus Biosciences, Inc. Transaction History